Is fecal calprotectin the next standard in inflammatory bowel disease activity tests?

被引：2

作者：

Alic, M

机构：

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 1999年 / 94卷 / 11期

关键词：

D O I：

10.1111/j.1572-0241.1999.03370.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

收藏

页码：3370 / 3371

页数：2

相关论文

共 10 条

[1] Bunn SK, 1999, GUT, V44, pA35
[2] Fecal marker variability in colorectal cancer: Calprotectin versus hemoglobin
Gilbert, JA
Ahlquist, DA
Mahoney, DW
Zinsmeister, AR
Rubin, J
Ellefson, RD
[J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 (10) : 1001 - 1005
[3] Johne B, 1997, J CLIN PATHOL-MOL PA, V50, P113
[4] LIMBURG P, 1998, ACG ANN M OCT BOST M
[5] Pimentel M, 1999, GASTROENTEROLOGY, V116, pA796
[6] Roseth AG, 1999, SCAND J GASTROENTERO, V34, P50
[7] Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein
Roseth, AG
Aadland, E
Jahnsen, J
Raknerud, N
[J]. DIGESTION, 1997, 58 (02) : 176 - 180
[8] ASSESSMENT OF THE NEUTROPHIL DOMINATING PROTEIN CALPROTECTIN IN FECES - A METHODOLOGIC STUDY
ROSETH, AG
FAGERHOL, MK
AADLAND, E
SCHJONSBY, H
[J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1992, 27 (09) : 793 - 798
[9] Schmidt PN, 1999, GASTROENTEROLOGY, V116, pA814
[10] Tibble JA, 1999, GUT, V44, pA35